Gastrointestinal dendritic cells promote Th2 skewing via OX40L

被引:110
作者
Blazquez, Ana Belen
Berin, M. Cecilia [1 ]
机构
[1] Mt Sinai Sch Med, Div Pediat Allergy & Immunol, New York, NY 10029 USA
关键词
D O I
10.4049/jimmunol.180.7.4441
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice can be sensitized to food proteins by oral administration with the adjuvant cholera toxin (CT), such that they undergo anaphylaxis when rechallenged with the sensitizing allergen. In contrast, feeding of Ags alone leads to oral tolerance. Our aim was to define the mechanisms by which gastrointestinal dendritic cells (DCs) participate in the deviation of tolerance to allergic sensitization in the gut in response to CT. BALB/c mice were fed with CT or PBS. The impact of CT on DC subsets in the mesenteric lymph node (MLN) was assessed by flow cytometry. Ag presentation assays were performed with DCs isolated from the MLN of PBS- or CT-fed mice, using OVA-specific CD4(+) T cells as responder cells. Gene expression in MLN DCs was determined by real-time PCR, and neutralizing Abs were used to test the function of OX40 ligand (OX40L) in Th2 skewing. Oral administration of CT induced an increase in the total CD11c(+) population in the MLN. CT induced a selective increase in migration of the CD11c(+)CD11b(-)CD8 alpha(-) DC subset and the maturation of all DC subsets. Maturation of DCs in vivo enhanced T cell proliferation and cytokine secretion. Oral CT induced up-regulation of Jagged-2 and OX40L by MLN DCs. Neutralizing anti-OX40L Abs completely abrogated the CT-induced Th2 cytokine response. We show that oral CT induces selective DC migration, maturation, and T cell priming activity in the MLN. Th2 skewing is mediated by OX40L, and we speculate that this molecule may be an important inducer of allergic sensitization to food allergens.
引用
收藏
页码:4441 / 4450
页数:10
相关论文
共 55 条
[11]   Rapid in vivo transport of proteins from digested allergen across pre-sensitized gut [J].
Chambers, SJ ;
Wickham, MSJ ;
Regoli, M ;
Bertelli, E ;
Gunning, PA ;
Nicoletti, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 325 (04) :1258-1263
[12]   Oral tolerance and its relation to food hypersensitivities [J].
Chehade, M ;
Mayer, L .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 115 (01) :3-12
[13]  
Cong YZ, 1997, J IMMUNOL, V159, P5301
[14]  
CORNELL R, 1971, LAB INVEST, V25, P42
[15]   CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1 [J].
Flynn, S ;
Toellner, KM ;
Raykundalia, C ;
Goodall, M ;
Lane, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :297-304
[16]   Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting [J].
Frey, A ;
Giannasca, KT ;
Weltzin, R ;
Giannasca, PJ ;
Reggio, H ;
Lencer, WI ;
Neutra, MR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1045-1059
[17]   IDENTIFICATION OF A HUMAN OX-40 LIGAND, A COSTIMULATOR OF CD4+ T-CELLS WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR [J].
GODFREY, WR ;
FAGNONI, FF ;
HARARA, MA ;
BUCK, D ;
ENGLEMAN, EG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :757-762
[18]   A neonatal swine model for peanut allergy [J].
Helm, RM ;
Furuta, GT ;
Stanley, JS ;
Ye, JH ;
Cockrell, G ;
Connaughton, C ;
Simpson, P ;
Bannon, GA ;
Burks, AW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) :136-142
[19]   Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma [J].
Hoshino, A ;
Tanaka, Y ;
Akiba, H ;
Asakura, Y ;
Mita, Y ;
Sakurai, T ;
Takaoka, A ;
Nakaike, S ;
Ishii, N ;
Sugamura, K ;
Yagita, H ;
Okumura, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (04) :861-869
[20]   The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells [J].
Imura, A ;
Hori, T ;
Imada, K ;
Ishikawa, T ;
Tanaka, Y ;
Maeda, M ;
Imamura, S ;
Uchiyama, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2185-2195